Abstract | INTRODUCTION:
Severe congenital neutropenia (SCN), a heterogeneous condition with onset at early ages, is characterised by primary myelopoiesis failure with an absolute neutrophil count (ANC) < 0.5 x10(9)/L, severe infections and risk of leukaemic transformation. OBJECTIVE: The aim of the study was to ascertain the long term outcome of patients with SCN. MATERIAL AND METHODS: The clinical features, diagnostic methods, treatment and outcome of 11 patients with SCN were analysed. RESULTS: The median age at diagnosis was 4 months (range: 3 days-12 years). The primary clinical manifestation was severe infection. Median ANC at diagnosis: 0.2 x 10(9)/L (range: 0-0.37). Bone marrow aspirate showed maturation arrest at promyelocyte stage in all cases. Genetic studies revealed 3 mutations, two in ELA-2 gene and 1 in G6PC3 gene, showing a correlation between genotype and phenotype. Granulocyte Colony Stimulating Factor ( G-CSF) was the first-line treatment in 9 patients; six of whom showed a good response at doses between 5 and 15 μg/kg/day for 3-7 days/week. The remaining 3 patients failed to respond to G-CSF and allogeneic stem cell transplantation (SCT) was indicated. Furthermore, SCT was the treatment of choice in two cases. Median follow-up of the cohort was 5 years (range: 1-10 years) with 100% survival and no cases of leukaemic transformation. CONCLUSIONS: We conclude that genetic study is useful for establishing a correlation between genotype and phenotype. The treatment of choice for SCN is G-CSF to which 2/3 of patients should respond; while SCT is reserved for cases of poor response or those evolving to myelodysplastic syndrome (MDS) or leukaemia; thus close follow-up of this condition is essential.
|
Authors | M Milá, A Rufach, J L Dapena, J I Arostegui, I Elorza, A Llort, J Sánchez de Toledo, C Díaz de Heredia |
Journal | Anales de pediatria (Barcelona, Spain : 2003)
(An Pediatr (Barc))
Vol. 75
Issue 6
Pg. 396-400
(Dec 2011)
ISSN: 1695-9531 [Electronic] Spain |
Vernacular Title | Neutropenia congénita grave: análisis de las características clínicas, estudios diagnósticos, tratamiento y seguimiento a largo plazo. |
PMID | 21757412
(Publication Type: Journal Article)
|
Copyright | Copyright © 2011 Asociación Española de Pediatría. Published by Elsevier Espana. All rights reserved. |
Topics |
- Child
- Child, Preschool
- Congenital Bone Marrow Failure Syndromes
- Female
- Humans
- Infant
- Infant, Newborn
- Male
- Neutropenia
(congenital, diagnosis, therapy)
- Time Factors
- Treatment Outcome
|